Medpace Holdings, Inc. Increase (Decrease) in Deferred Revenue
Medpace Holdings, Inc. (MEDP) reported Increase (Decrease) in Deferred Revenue of $6.82 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-05-01
- Medpace Holdings, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was $6.82M.
- Medpace Holdings, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $5.35M.
- Medpace Holdings, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was $2.67M, a 73.36% increase year-over-year.
- Medpace Holdings, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was $4.95M, a 7.40% decline year-over-year.
- Medpace Holdings, Inc. increase (decrease) in deferred revenue for fiscal 2017 was $7.74M, a 47.46% decline from fiscal 2016.
- Medpace Holdings, Inc. increase (decrease) in deferred revenue for fiscal 2016 was $14.72M.
- Medpace Holdings, Inc. increase (decrease) in deferred revenue for fiscal 2015 was -$7.00M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-03-31 | $6.82M 10-Q · filed 2018-05-01 | $12.17M derived: sum of 2 quarters · filed 2018-05-01 | $14.85M derived: sum of 3 quarters · filed 2018-05-01 | $19.80M derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-12-31 | $5.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $8.03M derived: sum of 2 quarters · filed 2018-02-27 | $12.98M derived: sum of 3 quarters · filed 2018-02-27 | $7.74M 10-K · filed 2018-02-27 |
| 2017-09-30 | $2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $7.63M derived: sum of 2 quarters · filed 2017-10-31 | $2.38M 10-Q · filed 2017-10-31 | $544.00K derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-06-30 | $4.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | -$294.00K 10-Q · filed 2017-08-01 | -$2.13M derived: sum of 3 quarters · filed 2018-05-01 | -$588.00K derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-03-31 | -$5.25M 10-Q · filed 2018-05-01 | -$7.08M derived: sum of 2 quarters · filed 2018-05-01 | -$5.54M derived: sum of 3 quarters · filed 2018-05-01 | -$192.00K derived: sum of 4 quarters · filed 2018-05-01 |
| 2016-12-31 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$294.00K derived: sum of 2 quarters · filed 2018-02-27 | $5.05M derived: sum of 3 quarters · filed 2018-02-27 | $14.72M 10-K · filed 2018-02-27 |
| 2016-09-30 | $1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $6.89M derived: sum of 2 quarters · filed 2017-10-31 | $16.56M 10-Q · filed 2017-10-31 | $16.79M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $5.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $15.02M 10-Q · filed 2017-08-01 | $15.25M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-03-31 | $9.67M 10-Q · filed 2017-05-02 | $9.90M derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$7.00M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | -$7.23M 10-Q · filed 2016-11-03 | |||
| 2014-12-31 | $6.00M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |